Anatomy of success: Biotech firm lays groundwork for big 2022

Despite an up-and-down year, Catalyst Orthoscience appears poised for takeoff in the new year. One big aid? It has a product surgeons and patients alike love.

File. Catalyst Orthoscience CEO Brian Hutchison has more than 30 years of experience in the medical device industry.
File. Catalyst Orthoscience CEO Brian Hutchison has more than 30 years of experience in the medical device industry.
  • Health Care
  • Share

Breakthrough would be an apt term for the year Catalyst Orthoscience just experienced. The Naples-based medical device company, hot off winning FDA approval for its innovative new reverse shoulder implant system, closed a $12.5 million funding round that will help it acquire more inventory and hire staff it will need to drive sales in 2022.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • April 1, 2026
Work starts on Naples apartments as developer secures $45M in financing
  • April 1, 2026
$300K Bradenton EDC contract up for vote in Manatee
  • April 1, 2026
27 Gulf Coast companies ranked among fastest growing in Southeast
  • April 1, 2026
Tampa tire store franchisor rolls into new brands, buys a restaurant

Sponsored Content